A Rare Case of Primary Cutaneous CD4+ Small/Medium Size T-Cell Lymphoproliferative Disorder Responding to Rituximab
Aggressive treatment is avoided in solitary lesions of PCS-TCLPD, but multiple lesions with no response to the conventional modalities may need more sophisticated management, including anti-CD20 rituximab.
Authors
- Maryam Daneshpazhooh (ORCID: https://orcid.org/0000-0003-1020-8895)
- Alireza Ghanadan (ORCID: https://orcid.org/0000-0002-5753-8288)
- Yasaman Sadeghi
- Hamidreza Mahmoudi (ORCID: https://orcid.org/0000-0002-1890-1005)
- Saman Al‐Zahawi (ORCID: https://orcid.org/0009-0003-7324-0347)
- Sara Masoomi
Institutions
- Razi Hospital (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Case Reports in Dermatology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1159/000545747
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00